Selective binding of bryostatin analogues to the cysteine rich domains of protein kinase C isozymes

Bioorganic and Medicinal Chemistry Letters

Volumn 9, Issue 12, 1999, Pages 1687-1690

  Wender, Paul A ^a   Lippa, Blaise ^a   Park, Cheol Min ^a   Irie, Kazuhiro ^b   Nakahara, Akifumi ^b   Ohigashi, Hajime ^b  

^a STANFORD UNIVERSITY   (United States)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BRYOSTATIN; CYSTEINE; ISOENZYME; PHORBOL DIBUTYRATE; PROTEIN KINASE C;

APOPTOSIS; ARTICLE; BINDING AFFINITY; CHEMICAL STRUCTURE; ENZYME ACTIVATION; ENZYME BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; TUMOR GROWTH;

ANTINEOPLASTIC AGENTS; BINDING, COMPETITIVE; CYSTEINE; ENZYME ACTIVATION; HUMANS; ISOENZYMES; LACTONES; MACROLIDES; PROTEIN CONFORMATION; PROTEIN KINASE C; PROTEIN KINASE C-DELTA; TUMOR CELLS, CULTURED;

EID: 0033591714     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(99)00263-2     Document Type: Article

References (19)

1. (a) Pettit, G. R.; Herald, C. L.; Doubek, D. L.; Herald, D. L.; Arnold, E.; Clardy, J. J. Am. Chem. Soc. 1982, 104, 6846.
2. (b) Pettit, G. R. J. Nat. Prod. 1996, 59, 812.
3. Current information on the scope and status of bryostatin clinical trials can be found on the NCI web page at: http://cancernet.nci.nih.gov/prot/patsrch.shtml
4. (a) DeVries, D. J.; Herald, C. L.; Pettit, G. R.; Blumberg, P. M. Biochem. Pharmacol. 1988, 37, 4069.
5. (b) Slater, S. J.; Ho, C.; Kelly, M. B.; Larkin, J. D.; Taddeo, F. J.; Yeager, M. D.; Stubbs, C. D. J. Biol. Chem. 1996, 271, 4627.
6. (c) Kraft, A. S.; Smith, J. B.; Berkow, R. L. Proc. Natl. Acad. Sci. U.S.A. 1986, 83, 1334.
7. (a) Wender, P. A.; De Brabander, J.; Harran, P. G.; Jimenez, J-M.; Koehler, M. F. T.; Lippa, B.; Park, C-M.; Shiozaki, M. J. Am. Chem. Soc. 1998, 120, 4534.
8. (b) Wender, P. A.; De Brabander, J.; Harran, P. G.; Jimenez, J-M.; Koehler, M. F. T.; Lippa, B.; Park, C-M.; Siedenbiedel, C.; Pettit, G. R. Proc. Natl. Acad. Sci. U.S.A. 1998, 95, 6624.
9. (c) Wender, P. A.; Harran, P. G.; Hinkle, K. W.; Lippa, B.; Pettit, G. R. Tetrahedron Lett. 1998, 39, 8625.
10. (a) Szallasi, Z.; Smith, C. B.; Pettit, G. R.; Blumberg, P. M. J. Biol. Chem. 1994, 269, 2118.
11. (b) Szallasi, Z.; Denning, M. F.; Smith, C. B.; Dlugosz, A. A.; Yuspa, S. H.; Pettit, G. R.; Blumberg, P. M. Mol. Pharmacol. 1994, 46, 840.
12. (c) Szallasi, Z.; Kosa, K.; Smith, C. B.; Dlugosz, A. A.; Williams, E. K.; Yuspa, S. H.; Blumberg, P. M. Mol. Pharmacol. 1995, 47, 258.
13. (d) Lu, Z. M.; Hornia, A.; Jiang, Y. W.; Zang, Q.; Ohno, S.; Foster, D. A. Mol. Cell. Biol. 1997, 17, 3418.
14. (a) Fukumoto, S.; Nishizawa, Y.; Hosoi, M.; Koyama, H.; Yamakawa, K.; Ohno, S.; Morii, H. J. Biol. Chem. 1997, 272, 13816.
15. (b) Ghayur, B. T.; Hugunin, M.; Talanian, R. V.; Ratnofsky, S.; Quinlan, C.; Emoto, Y.; Pandey, P.; Datta, R.; Huang, Y. Y.; Kharbanda, S.; Allen, H.; Kamen, R.; Wong, W.; Kufe, D. J. Exp. Med. 1996, 184, 2399.
16. Bögi, K.; Lorenzo, P. S.; Szallasi, Z.; Acs, P.; Wagner, G. S.; Blumberg, P. M. Cancer Res. 1998, 58, 1423.
17. (a) Wender, P. A.; Irie, K.; Miller, B. L. Proc. Natl. Acad. Sci. U.S.A. 1995, 92, 239.
18. (b) Irie, K.; Oie, K.; Nakahara, A.; Yanai, Y.; Ohigashi, H.; Wender, P. A.; Fukuda, H.; Konishi, H.; Kikkawa, U. J. Am. Chem. Soc. 1998, 720, 9159.
19. Kazanietz, M. G.; Lewin, N. E.; Gao, F.; Pettit, G. R.; Blumberg, P. M. Mol. Pharmacol. 1994, 46, 374, and references cited therein.